Vitality Watch

⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.

Mentioned 1× · first seen 09-sep-2026 · last seen 09-sep-2026

LAPTM5–WWP2–OPTN Mitophagy Axis in RPE Aging

Current understanding

LAPTM5 is proposed to accelerate retinal pigment epithelium (RPE) senescence and subretinal fibrosis by driving WWP2 degradation, thereby destabilizing OPTN-mediated mitophagy and permitting cytosolic mtDNA leakage that activates cGAS–STING [animal-model]. In a D-galactose accelerated-aging mouse model, RPE-specific AAV knockdown of LAPTM5 or pharmacological STING inhibition attenuates fibrotic lesions [animal-model]. The axis is preclinical and D-gal-model-specific; whether it operates in natural retinal aging or age-related macular degeneration in humans is untested.

Evidence log

Open questions

Related

Contributing findings

pubmed preclinical
LAPTM5 correlates with RPE senescence and subretinal fibrosis through the LAPTM5-WWP2-OPTN mitophagy cascade and cGAS/STING activation in a D-galactose-induced aging model.
08-sep-2026 novelty 3 per-area 3 introduces

build build 880 · 2bcef25 · 2026-11-18